首页 > 最新文献

Journal of Transplantation最新文献

英文 中文
Manipulation of Ovarian Function Significantly Influenced Sarcopenia in Postreproductive-Age Mice 卵巢功能调节对生育年龄小鼠肌肉减少症有显著影响
IF 2.5 Pub Date : 2016-09-22 DOI: 10.1155/2016/4570842
Rhett L. Peterson, Kate C Parkinson, J. Mason
Previously, transplantation of ovaries from young cycling mice into old postreproductive-age mice increased life span. We anticipated that the same factors that increased life span could also influence health span. Female CBA/J mice received new (60 d) ovaries at 12 and 17 months of age and were evaluated at 16 and 25 months of age, respectively. There were no significant differences in body weight among any age or treatment group. The percentage of fat mass was significantly increased at 13 and 16 months of age but was reduced by ovarian transplantation in 16-month-old mice. The percentages of lean body mass and total body water were significantly reduced in 13-month-old control mice but were restored in 16- and 25-month-old recipient mice by ovarian transplantation to the levels found in six-month-old control mice. In summary, we have shown that skeletal muscle mass, which is negatively influenced by aging, can be positively influenced or restored by reestablishment of active ovarian function in aged female mice. These findings provide strong incentive for further investigation of the positive influence of young ovaries on restoration of health in postreproductive females.
在此之前,将年轻小鼠的卵巢移植到处于生育年龄的老年小鼠中可以延长寿命。我们预计,延长寿命的同样因素也可能影响健康寿命。雌性CBA/J小鼠分别在12月龄和17月龄时接受新卵巢(60 d),并在16月龄和25月龄时进行评估。在任何年龄或治疗组中,体重没有显著差异。在13和16月龄时,脂肪质量百分比显著增加,但在16月龄的小鼠中,卵巢移植降低了脂肪质量百分比。在13个月大的对照组小鼠中,瘦体重和全身水分的百分比显著降低,但在16和25个月大的受体小鼠中,通过卵巢移植,瘦体重和全身水分的百分比恢复到6个月大的对照组小鼠的水平。综上所述,我们已经证明,骨骼肌质量受到衰老的负面影响,可以通过重建活跃的卵巢功能来积极影响或恢复老年雌性小鼠。这些发现为进一步研究年轻卵巢对生殖后女性健康恢复的积极影响提供了强有力的动力。
{"title":"Manipulation of Ovarian Function Significantly Influenced Sarcopenia in Postreproductive-Age Mice","authors":"Rhett L. Peterson, Kate C Parkinson, J. Mason","doi":"10.1155/2016/4570842","DOIUrl":"https://doi.org/10.1155/2016/4570842","url":null,"abstract":"Previously, transplantation of ovaries from young cycling mice into old postreproductive-age mice increased life span. We anticipated that the same factors that increased life span could also influence health span. Female CBA/J mice received new (60 d) ovaries at 12 and 17 months of age and were evaluated at 16 and 25 months of age, respectively. There were no significant differences in body weight among any age or treatment group. The percentage of fat mass was significantly increased at 13 and 16 months of age but was reduced by ovarian transplantation in 16-month-old mice. The percentages of lean body mass and total body water were significantly reduced in 13-month-old control mice but were restored in 16- and 25-month-old recipient mice by ovarian transplantation to the levels found in six-month-old control mice. In summary, we have shown that skeletal muscle mass, which is negatively influenced by aging, can be positively influenced or restored by reestablishment of active ovarian function in aged female mice. These findings provide strong incentive for further investigation of the positive influence of young ovaries on restoration of health in postreproductive females.","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/4570842","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64387059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch 补体依赖性细胞毒性交叉配型阴性肾移植候选人供体特异性抗体的C1Q检测结果:在预测血流交叉配型时,高特异性但低敏感性
IF 2.5 Pub Date : 2016-09-04 DOI: 10.1155/2016/2106028
J. M. Arreola-Guerra, N. Castelán, A. de Santiago, A. Arvizu, Norma González-Tableros, Mayra López, I. Salcedo, M. Vilatoba, J. Granados, L. Morales-Buenrostro, J. Alberú
The aim of the present study was to describe the association of positive flow cross match (FXM) and C1q-SAB. Methods. In this observational, cross-sectional, and comparative study, patients included had negative AHG-CDC-XM and donor specific antibodies (DSA) and were tested with FXM. All pretransplant sera were tested with C1q-SAB assay. Results. A total of 50 donor/recipient evaluations were conducted; half of them had at least one C1q+ Ab (n = 26, 52%). Ten patients (20.0%) had DSA C1q+ Ab. Twenty-five (50%) FXMs were positive. Factors associated with a positive FXM were the presence of C1q+ Ab (DSA C1q+ Ab: OR 27, 2.80–259.56, P = 0.004, and no DSA C1q+ Ab: OR 5, 1.27–19.68, P = 0.021) and the DSA LABScreen-SAB MFI (OR 1.26, 95% CI 1.06–1.49, P = 0.007). The cutoff point of immunodominant LABScreen SAB DSA-MFI with the greatest sensitivity and specificity to predict FXM was 2,300 (sensitivity: 72% and specificity: 75%). For FXM prediction, DSA C1q+ Ab was the most specific (95.8%, 85–100) and the combination of DSA-MFI > 2,300 and C1q+ Ab was the most sensitive (92.0%, 79.3–100). Conclusions. C1q+ Ab and LABScreen SAB DSA-MFI were significantly associated with FXM. DSA C1q+ Ab was highly specific but with low sensitivity.
本研究的目的是描述正流交叉匹配(FXM)与C1q-SAB的关系。方法。在这项观察性、横断面和比较研究中,纳入的患者AHG-CDC-XM和供体特异性抗体(DSA)均为阴性,并进行了FXM检测。所有移植前血清均采用C1q-SAB检测。结果。总共进行了50次捐助国/受援国评价;半数患者至少有一种C1q+ Ab (n = 26, 52%)。10例(20.0%)DSA C1q+ Ab, 25例(50%)FXMs阳性。与FXM阳性相关的因素是C1q+ Ab的存在(DSA C1q+ Ab: OR 27, 2.80-259.56, P = 0.004,无DSA C1q+ Ab: OR 5, 1.27-19.68, P = 0.021)和DSA LABScreen-SAB MFI (OR 1.26, 95% CI 1.06-1.49, P = 0.007)。免疫优势的LABScreen SAB DSA-MFI预测FXM的灵敏度和特异性最高的截止点为2300(灵敏度为72%,特异性为75%)。对于FXM的预测,DSA C1q+ Ab的特异性最高(95.8%,85-100),DSA- mfi bbb2300与C1q+ Ab的联合预测敏感性最高(92.0%,79.3-100)。结论。C1q+ Ab和LABScreen SAB DSA-MFI与FXM显著相关。DSA C1q+ Ab特异度高,敏感性低。
{"title":"C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch","authors":"J. M. Arreola-Guerra, N. Castelán, A. de Santiago, A. Arvizu, Norma González-Tableros, Mayra López, I. Salcedo, M. Vilatoba, J. Granados, L. Morales-Buenrostro, J. Alberú","doi":"10.1155/2016/2106028","DOIUrl":"https://doi.org/10.1155/2016/2106028","url":null,"abstract":"The aim of the present study was to describe the association of positive flow cross match (FXM) and C1q-SAB. Methods. In this observational, cross-sectional, and comparative study, patients included had negative AHG-CDC-XM and donor specific antibodies (DSA) and were tested with FXM. All pretransplant sera were tested with C1q-SAB assay. Results. A total of 50 donor/recipient evaluations were conducted; half of them had at least one C1q+ Ab (n = 26, 52%). Ten patients (20.0%) had DSA C1q+ Ab. Twenty-five (50%) FXMs were positive. Factors associated with a positive FXM were the presence of C1q+ Ab (DSA C1q+ Ab: OR 27, 2.80–259.56, P = 0.004, and no DSA C1q+ Ab: OR 5, 1.27–19.68, P = 0.021) and the DSA LABScreen-SAB MFI (OR 1.26, 95% CI 1.06–1.49, P = 0.007). The cutoff point of immunodominant LABScreen SAB DSA-MFI with the greatest sensitivity and specificity to predict FXM was 2,300 (sensitivity: 72% and specificity: 75%). For FXM prediction, DSA C1q+ Ab was the most specific (95.8%, 85–100) and the combination of DSA-MFI > 2,300 and C1q+ Ab was the most sensitive (92.0%, 79.3–100). Conclusions. C1q+ Ab and LABScreen SAB DSA-MFI were significantly associated with FXM. DSA C1q+ Ab was highly specific but with low sensitivity.","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/2106028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64261801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect 受体和供体肥胖匹配对肝移植结果的影响:并非所有匹配都是完美的
IF 2.5 Pub Date : 2016-09-01 DOI: 10.1155/2016/9709430
E. Beal, D. Tumin, L. Conteh, A. Hanje, Anthony J. Michaels, D. Hayes, S. Black, K. Mumtaz
There is a paucity of literature examining recipient-donor obesity matching on liver transplantation outcomes. The United Network for Organ Sharing database was queried for first-time recipients of liver transplant whose age was ≥18 between January 2003 and September 2013. Outcomes including patient and graft survival at 30 days, 1 year, and 5 years and overall, liver retransplantation, and length of stay were compared between nonobese recipients receiving a graft from nonobese donors and obese recipient-obese donor, obese recipient-nonobese donor, and nonobese recipient-obese donor pairs. 51,556 LT recipients were identified, including 34,217 (66%) nonobese and 17,339 (34%) obese recipients. The proportions of patients receiving an allograft from an obese donor were 24% and 29%, respectively, among nonobese and obese recipients. Graft loss (HR: 1.27; 95% CI: 1.09–1.46; p = 0.002) and mortality (HR: 1.38; 95% CI: 1.16–1.65; p < 0.001) at 30 days were increased in the obese recipient-obese donor pair. However, 1-year graft (HR: 0.83; 95% CI: 0.74–0.93; p = 0.002) and patient (HR: 0.84; 95% CI: 0.74–0.95; p = 0.007) survival and overall patient (HR: 0.93; 95% CI: 0.86–1.00; p = 0.042) survival were favorable. There is evidence of recipient and donor obesity disadvantage early, but survival curves demonstrate improved long-term outcomes. It is important to consider obesity in the donor-recipient match.
关于供体-受体肥胖匹配对肝移植结果影响的研究文献很少。在联合器官共享网络数据库中查询了2003年1月至2013年9月期间年龄≥18岁的首次肝移植受者。结果包括患者和移植物在30天、1年和5年的生存以及总体、肝脏再移植和住院时间在非肥胖受体接受非肥胖供体、肥胖受体-肥胖供体、肥胖受体-非肥胖供体和非肥胖受体-肥胖供体之间进行比较。确定了51,556例肝移植受者,包括34,217例(66%)非肥胖受者和17,339例(34%)肥胖受者。在非肥胖和肥胖受体中,接受肥胖供体异体移植的患者比例分别为24%和29%。移植物损失(HR: 1.27;95% ci: 1.09-1.46;p = 0.002)和死亡率(HR: 1.38;95% ci: 1.16-1.65;P < 0.001),在肥胖的受体-肥胖的供体组中增加。然而,1年移植(HR: 0.83;95% ci: 0.74-0.93;p = 0.002)和患者(HR: 0.84;95% ci: 0.74-0.95;p = 0.007)生存率和总患者(HR: 0.93;95% ci: 0.86-1.00;P = 0.042)生存率较好。有证据表明,早期受体和供体肥胖不利,但生存曲线显示改善的长期结果。在供体-受体匹配中考虑肥胖是很重要的。
{"title":"Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect","authors":"E. Beal, D. Tumin, L. Conteh, A. Hanje, Anthony J. Michaels, D. Hayes, S. Black, K. Mumtaz","doi":"10.1155/2016/9709430","DOIUrl":"https://doi.org/10.1155/2016/9709430","url":null,"abstract":"There is a paucity of literature examining recipient-donor obesity matching on liver transplantation outcomes. The United Network for Organ Sharing database was queried for first-time recipients of liver transplant whose age was ≥18 between January 2003 and September 2013. Outcomes including patient and graft survival at 30 days, 1 year, and 5 years and overall, liver retransplantation, and length of stay were compared between nonobese recipients receiving a graft from nonobese donors and obese recipient-obese donor, obese recipient-nonobese donor, and nonobese recipient-obese donor pairs. 51,556 LT recipients were identified, including 34,217 (66%) nonobese and 17,339 (34%) obese recipients. The proportions of patients receiving an allograft from an obese donor were 24% and 29%, respectively, among nonobese and obese recipients. Graft loss (HR: 1.27; 95% CI: 1.09–1.46; p = 0.002) and mortality (HR: 1.38; 95% CI: 1.16–1.65; p < 0.001) at 30 days were increased in the obese recipient-obese donor pair. However, 1-year graft (HR: 0.83; 95% CI: 0.74–0.93; p = 0.002) and patient (HR: 0.84; 95% CI: 0.74–0.95; p = 0.007) survival and overall patient (HR: 0.93; 95% CI: 0.86–1.00; p = 0.042) survival were favorable. There is evidence of recipient and donor obesity disadvantage early, but survival curves demonstrate improved long-term outcomes. It is important to consider obesity in the donor-recipient match.","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/9709430","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64634597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Liver Transplantation for Hepatocellular Carcinoma: A Single Center Resume Overlooking Four Decades of Experience 肝细胞癌的肝移植:单中心简历忽视四十年的经验
IF 2.5 Pub Date : 2016-01-10 DOI: 10.1155/2016/7895956
N. Emmanouilidis, Rickmer Peters, B. Ringe, Z. Güner, W. Ramackers, H. Bektas, F. Lehner, M. Manns, J. Klempnauer, H. Schrem
Background. This is a single center oncological resume overlooking four decades of experience with liver transplantation (LT) for hepatocellular carcinoma (HCC). Methods. All 319 LT for HCC that were performed between 1975 and 2011 were included. Predictors for HCC recurrence (HCCR) and survival were identified by Cox regression, Kaplan-Meier analysis, Log Rank, and χ 2-tests where appropriate. Results. HCCR was the single strongest hazard for survival (exp⁡(B) = 10.156). Hazards for HCCR were tumor staging beyond the histologic MILAN (exp⁡(B) = 3.645), bilateral tumor spreading (exp⁡(B) = 14.505), tumor grading beyond G2 (exp⁡(B) = 8.668), and vascular infiltration of small or large vessels (exp⁡(B) = 11.612, exp⁡(B) = 18.324, resp.). Grading beyond G2 (exp⁡(B) = 10.498) as well as small and large vascular infiltrations (exp⁡(B) = 13.337, exp⁡(B) = 16.737, resp.) was associated with higher hazard ratios for long-term survival as compared to liver transplantation beyond histological MILAN (exp⁡(B) = 4.533). Tumor dedifferentiation significantly correlated with vascular infiltration (χ 2 p = 0.006) and intrahepatic tumor spreading (χ 2 p = 0.016). Conclusion. LT enables survival from HCC. HCC dedifferentiation is associated with vascular infiltration and intrahepatic tumor spreading and is a strong hazard for HCCR and survival. Pretransplant tumor staging should include grading by biopsy, because grading is a reliable and easily accessible predictor of HCCR and survival. Detection of dedifferentiation should speed up the allocation process.
背景。这是一份单中心肿瘤学简历,回顾了40年来肝移植治疗肝细胞癌(HCC)的经验。方法。在1975年至2011年期间接受肝细胞癌肝移植的319例患者均被纳入其中。通过Cox回归、Kaplan-Meier分析、Log Rank和χ 2检验确定HCC复发(HCCR)和生存的预测因素。结果。HCCR是最大的生存风险(exp (B) = 10.156)。HCCR的危险因素为肿瘤分期超过组织学MILAN (exp (B) = 3.645),双侧肿瘤扩散(exp (B) = 14.505),肿瘤分级超过G2 (exp (B) = 8.668),小血管或大血管浸润(exp (B) = 11.612, exp (B) = 18.324,分别为0.05和0.05)。分级超过G2 (exp (B) = 10.498)以及小血管和大血管浸润(exp (B) = 13.337, exp (B) = 16.737,分别)与肝移植超过组织学MILAN (exp (B) = 4.533)的长期生存风险比相关。肿瘤去分化与血管浸润(χ 2 p = 0.006)和肝内肿瘤扩散(χ 2 p = 0.016)显著相关。结论。肝移植可使HCC存活。HCC去分化与血管浸润和肝内肿瘤扩散有关,对HCCR和生存有很大的危害。移植前肿瘤分期应包括活检分级,因为分级是可靠且容易获得的HCCR和生存率预测指标。去分化的检测应该会加快分配过程。
{"title":"Liver Transplantation for Hepatocellular Carcinoma: A Single Center Resume Overlooking Four Decades of Experience","authors":"N. Emmanouilidis, Rickmer Peters, B. Ringe, Z. Güner, W. Ramackers, H. Bektas, F. Lehner, M. Manns, J. Klempnauer, H. Schrem","doi":"10.1155/2016/7895956","DOIUrl":"https://doi.org/10.1155/2016/7895956","url":null,"abstract":"Background. This is a single center oncological resume overlooking four decades of experience with liver transplantation (LT) for hepatocellular carcinoma (HCC). Methods. All 319 LT for HCC that were performed between 1975 and 2011 were included. Predictors for HCC recurrence (HCCR) and survival were identified by Cox regression, Kaplan-Meier analysis, Log Rank, and χ 2-tests where appropriate. Results. HCCR was the single strongest hazard for survival (exp⁡(B) = 10.156). Hazards for HCCR were tumor staging beyond the histologic MILAN (exp⁡(B) = 3.645), bilateral tumor spreading (exp⁡(B) = 14.505), tumor grading beyond G2 (exp⁡(B) = 8.668), and vascular infiltration of small or large vessels (exp⁡(B) = 11.612, exp⁡(B) = 18.324, resp.). Grading beyond G2 (exp⁡(B) = 10.498) as well as small and large vascular infiltrations (exp⁡(B) = 13.337, exp⁡(B) = 16.737, resp.) was associated with higher hazard ratios for long-term survival as compared to liver transplantation beyond histological MILAN (exp⁡(B) = 4.533). Tumor dedifferentiation significantly correlated with vascular infiltration (χ 2 p = 0.006) and intrahepatic tumor spreading (χ 2 p = 0.016). Conclusion. LT enables survival from HCC. HCC dedifferentiation is associated with vascular infiltration and intrahepatic tumor spreading and is a strong hazard for HCCR and survival. Pretransplant tumor staging should include grading by biopsy, because grading is a reliable and easily accessible predictor of HCCR and survival. Detection of dedifferentiation should speed up the allocation process.","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/7895956","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64538407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Kidney Transplant Evaluation Process in the Elderly: Reasons for Being Turned down and Opportunities to Improve Cost-Effectiveness in a Single Center. 老年人肾移植评估过程:在单一中心被拒绝的原因和提高成本效益的机会。
IF 2.5 Pub Date : 2016-01-01 Epub Date: 2016-08-04 DOI: 10.1155/2016/7405930
Beatrice P Concepcion, Rachel C Forbes, Aihua Bian, Heidi M Schaefer

Background. The kidney transplant evaluation process for older candidates is complex due to the presence of multiple comorbid conditions. Methods. We retrospectively reviewed patients ≥60 years referred to our center for kidney transplantation over a 3-year period. Variables were collected to identify reasons for patients being turned down and to determine the number of unnecessary tests performed. Statistical analysis was performed to estimate the association between clinical predictors and listing status. Results. 345 patients were included in the statistical analysis. 31.6% of patients were turned down: 44% due to coronary artery disease (CAD), peripheral vascular disease (PVD), or both. After adjustment for patient demographics and comorbid conditions, history of CAD, PVD, or both (OR = 1.75, 95% CI (1.20, 2.56), p = 0.004), chronic obstructive pulmonary disease (OR = 8.75, 95% CI (2.81, 27.20), p = 0.0002), and cancer (OR 2.59, 95% CI (1.18, 5.67), p = 0.02) were associated with a higher risk of being turned down. 14.8% of patients underwent unnecessary basic testing and 9.6% underwent unnecessary supplementary testing with the charges over a 3-year period estimated at $304,337. Conclusion. A significant number of older candidates are deemed unacceptable for kidney transplantation with primary reasons cited as CAD and PVD. The overall burden of unnecessary testing is substantial and potentially avoidable.

背景。由于存在多种合并症,老年候选人的肾移植评估过程很复杂。方法。我们回顾性地回顾了3年内到我们中心进行肾移植的≥60岁的患者。收集变量以确定患者被拒绝的原因,并确定进行不必要检查的次数。进行统计分析以估计临床预测因子与上市状态之间的关联。结果:345例患者纳入统计分析。31.6%的患者被拒绝:44%是由于冠状动脉疾病(CAD),外周血管疾病(PVD),或两者兼而有之。在对患者人口统计学和合并症进行调整后,CAD、PVD或两者的病史(or = 1.75, 95% CI (1.20, 2.56), p = 0.004)、慢性阻塞性肺疾病(or = 8.75, 95% CI (2.81, 27.20), p = 0.0002)和癌症(or 2.59, 95% CI (1.18, 5.67), p = 0.02)与被拒绝的高风险相关。14.8%的患者接受了不必要的基本检查,9.6%的患者接受了不必要的补充检查,3年期间的费用估计为304,337美元。结论。大量老年候选人被认为不适合肾移植,主要原因是CAD和PVD。不必要的测试的总体负担是巨大的,并且可能是可以避免的。
{"title":"The Kidney Transplant Evaluation Process in the Elderly: Reasons for Being Turned down and Opportunities to Improve Cost-Effectiveness in a Single Center.","authors":"Beatrice P Concepcion,&nbsp;Rachel C Forbes,&nbsp;Aihua Bian,&nbsp;Heidi M Schaefer","doi":"10.1155/2016/7405930","DOIUrl":"https://doi.org/10.1155/2016/7405930","url":null,"abstract":"<p><p>Background. The kidney transplant evaluation process for older candidates is complex due to the presence of multiple comorbid conditions. Methods. We retrospectively reviewed patients ≥60 years referred to our center for kidney transplantation over a 3-year period. Variables were collected to identify reasons for patients being turned down and to determine the number of unnecessary tests performed. Statistical analysis was performed to estimate the association between clinical predictors and listing status. Results. 345 patients were included in the statistical analysis. 31.6% of patients were turned down: 44% due to coronary artery disease (CAD), peripheral vascular disease (PVD), or both. After adjustment for patient demographics and comorbid conditions, history of CAD, PVD, or both (OR = 1.75, 95% CI (1.20, 2.56), p = 0.004), chronic obstructive pulmonary disease (OR = 8.75, 95% CI (2.81, 27.20), p = 0.0002), and cancer (OR 2.59, 95% CI (1.18, 5.67), p = 0.02) were associated with a higher risk of being turned down. 14.8% of patients underwent unnecessary basic testing and 9.6% underwent unnecessary supplementary testing with the charges over a 3-year period estimated at $304,337. Conclusion. A significant number of older candidates are deemed unacceptable for kidney transplantation with primary reasons cited as CAD and PVD. The overall burden of unnecessary testing is substantial and potentially avoidable. </p>","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/7405930","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34350884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Clinical Course and Outcomes of Late Kidney Allograft Dysfunction. 晚期同种异体肾移植功能障碍的临床过程和结果。
IF 2.5 Pub Date : 2016-01-01 Epub Date: 2016-07-10 DOI: 10.1155/2016/7401808
Viktor Denisov, Vadym Zakharov, Anna Ksenofontova, Eugene Onishchenko, Tatyana Golubova, Sergey Kichatyi, Olga Zakharova

Background. This study is provided to increase the efficiency of the treatment of kidney transplant recipients by predicting the development of the late allotransplant dysfunction. Methods. 330 patients who have lived for more than one year with functioning kidney allograft were evaluated. To predict the subsequent duration of the well-functioning of allotransplant the prognostic significance of 15 baseline clinical and sociodemographic characteristics on the results of the survey one year after transplantation was investigated. The result was considered to be positive in constructing the regression prognostication model if recipient lived more than 3 years from the time of transplantation. Results. It was established that more late start of renal allograft dysfunction after transplantation correlates with the more time it takes till complete loss of allograft function. Creatinine and hemoglobin blood concentration and the level of proteinuria one year after transplantation within created mathematical model allow predicting the loss of kidney transplant function three years after the transplantation. Patients with kidney transplant dysfunction are advised to renew the program hemodialysis upon reaching plasma creatinine concentration 0.5-0.7 mmol/L. Conclusion. Values of creatinine, hemoglobin, and proteinuria one year after transplantation can be used for subsequent prognostication of kidney transplant function.

背景。本研究旨在通过预测晚期异体移植功能障碍的发展来提高肾移植受者的治疗效率。方法:对330例同种异体移植肾存活1年以上的患者进行评价。为了预测同种异体移植术后功能良好的持续时间,研究了15项基线临床和社会人口学特征对移植后1年调查结果的预后意义。如果移植后存活时间超过3年,该结果对构建回归预测模型具有积极意义。结果。研究表明,移植后肾移植功能开始越晚,移植后肾移植功能完全丧失所需的时间越长。在建立的数学模型中,移植后一年内血肌酐和血红蛋白浓度以及蛋白尿水平可以预测移植后三年内肾移植功能的丧失。肾移植功能障碍患者血浆肌酐浓度达到0.5-0.7 mmol/L时,建议重新进行血液透析。结论。移植后1年的肌酐、血红蛋白和蛋白尿值可用于后续肾移植功能的预测。
{"title":"Clinical Course and Outcomes of Late Kidney Allograft Dysfunction.","authors":"Viktor Denisov,&nbsp;Vadym Zakharov,&nbsp;Anna Ksenofontova,&nbsp;Eugene Onishchenko,&nbsp;Tatyana Golubova,&nbsp;Sergey Kichatyi,&nbsp;Olga Zakharova","doi":"10.1155/2016/7401808","DOIUrl":"https://doi.org/10.1155/2016/7401808","url":null,"abstract":"<p><p>Background. This study is provided to increase the efficiency of the treatment of kidney transplant recipients by predicting the development of the late allotransplant dysfunction. Methods. 330 patients who have lived for more than one year with functioning kidney allograft were evaluated. To predict the subsequent duration of the well-functioning of allotransplant the prognostic significance of 15 baseline clinical and sociodemographic characteristics on the results of the survey one year after transplantation was investigated. The result was considered to be positive in constructing the regression prognostication model if recipient lived more than 3 years from the time of transplantation. Results. It was established that more late start of renal allograft dysfunction after transplantation correlates with the more time it takes till complete loss of allograft function. Creatinine and hemoglobin blood concentration and the level of proteinuria one year after transplantation within created mathematical model allow predicting the loss of kidney transplant function three years after the transplantation. Patients with kidney transplant dysfunction are advised to renew the program hemodialysis upon reaching plasma creatinine concentration 0.5-0.7 mmol/L. Conclusion. Values of creatinine, hemoglobin, and proteinuria one year after transplantation can be used for subsequent prognostication of kidney transplant function. </p>","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/7401808","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34720600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Utility of Routine Ultrasound Imaging after Elective Transplant Ureteric Stent Removal. 择期输尿管支架置换术后常规超声成像的应用。
IF 2.5 Pub Date : 2016-01-01 Epub Date: 2016-07-14 DOI: 10.1155/2016/1231567
Bibek Das, Dorian Hobday, Jonathon Olsburgh, Chris Callaghan

Background. Ureteric stent insertion during kidney transplantation reduces the incidence of major urological complications (MUCs). We evaluated whether routine poststent removal graft ultrasonography (PSRGU) was useful in detecting MUCs before they became clinically or biochemically apparent. Methods. A retrospective analysis was undertaken of clinical outcomes following elective stent removals from adult single renal transplant recipients (sRTRs) at our centre between 1 January 2011 and 31 December 2013. Results. Elective stent removal was performed for 338 sRTRs. Of these patients, 222 had routine PSRGU (median (IQR) days after stent removal = 18 (11-31)), 79 had urgent PSRGU due to clinical or biochemical indications, 12 had CT imaging, and 25 had no further renal imaging. Of the 222 sRTRs who underwent routine PSRGU, 210 (94.6%) had no change of management, three (1.4%) required repeat imaging only, and eight patients (3.6%) had incidental (nonureteric) findings. One patient (0.5%) had nephrostomy insertion as a result of routine PSRGU findings, but no ureteric stenosis was identified. Of 79 patients having urgent PSRGU after elective stent removal, three patients required transplant ureteric reimplantation. Conclusions. This analysis found no evidence that routine PSRGU at two to three weeks after elective stent removal provides any added value beyond standard clinical and biochemical monitoring.

背景。肾移植期间输尿管支架置入可减少主要泌尿系统并发症(MUCs)的发生率。我们评估了常规支架移除后移植超声检查(PSRGU)在MUCs临床或生化表现明显之前是否有用。方法。回顾性分析本中心2011年1月1日至2013年12月31日期间成人单肾移植受者(sRTRs)择期支架移除后的临床结果。结果。338例srtr患者行择期支架取出术。在这些患者中,222例为常规PSRGU(支架取出后的中位(IQR)天= 18(11-31)),79例因临床或生化适应症而紧急PSRGU, 12例进行了CT成像,25例没有进一步的肾脏影像学检查。在222例接受常规PSRGU的srtr患者中,210例(94.6%)没有改变治疗方法,3例(1.4%)只需要重复成像,8例(3.6%)有偶发(非输尿管)发现。1例患者(0.5%)因常规PSRGU检查结果行肾造口术,但未发现输尿管狭窄。79例择期支架取出后出现紧急PSRGU的患者中,3例患者需要输尿管移植再植。结论。该分析发现,在选择性支架移除后2 - 3周的常规PSRGU除了标准的临床和生化监测外,没有任何证据表明其有任何附加价值。
{"title":"The Utility of Routine Ultrasound Imaging after Elective Transplant Ureteric Stent Removal.","authors":"Bibek Das,&nbsp;Dorian Hobday,&nbsp;Jonathon Olsburgh,&nbsp;Chris Callaghan","doi":"10.1155/2016/1231567","DOIUrl":"https://doi.org/10.1155/2016/1231567","url":null,"abstract":"<p><p>Background. Ureteric stent insertion during kidney transplantation reduces the incidence of major urological complications (MUCs). We evaluated whether routine poststent removal graft ultrasonography (PSRGU) was useful in detecting MUCs before they became clinically or biochemically apparent. Methods. A retrospective analysis was undertaken of clinical outcomes following elective stent removals from adult single renal transplant recipients (sRTRs) at our centre between 1 January 2011 and 31 December 2013. Results. Elective stent removal was performed for 338 sRTRs. Of these patients, 222 had routine PSRGU (median (IQR) days after stent removal = 18 (11-31)), 79 had urgent PSRGU due to clinical or biochemical indications, 12 had CT imaging, and 25 had no further renal imaging. Of the 222 sRTRs who underwent routine PSRGU, 210 (94.6%) had no change of management, three (1.4%) required repeat imaging only, and eight patients (3.6%) had incidental (nonureteric) findings. One patient (0.5%) had nephrostomy insertion as a result of routine PSRGU findings, but no ureteric stenosis was identified. Of 79 patients having urgent PSRGU after elective stent removal, three patients required transplant ureteric reimplantation. Conclusions. This analysis found no evidence that routine PSRGU at two to three weeks after elective stent removal provides any added value beyond standard clinical and biochemical monitoring. </p>","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/1231567","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34733846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation. 肝移植术后偶然发现的肝细胞癌的发生率、特点及预后。
IF 2.5 Pub Date : 2016-01-01 Epub Date: 2016-06-15 DOI: 10.1155/2016/1916387
Walid El Moghazy, Samy Kashkoush, Glenda Meeberg, Norman Kneteman

Background. We aimed to assess incidentally discovered hepatocellular carcinoma (iHCC) over time and to compare outcome to preoperatively diagnosed hepatocellular carcinoma (pdHCC) and nontumor liver transplants. Methods. We studied adults transplanted with a follow-up of at least one year. Patients were divided into 3 groups according to diagnosis of hepatocellular carcinoma. Results. Between 1990 and 2010, 887 adults were transplanted. Among them, 121 patients (13.6%) had pdHCC and 32 patients (3.6%) had iHCC; frequency of iHCC decreased markedly over years, in parallel with significant increase in pdHCC. Between 1990 and 1995, 120 patients had liver transplants, 4 (3.3%) of them had iHCC, and only 3 (2.5%) had pdHCC, while in the last 5 years, 263 patients were transplanted, 7 (0.03%) of them had iHCC, and 66 (25.1%) had pdHCC (P < 0.001). There was no significant difference between groups regarding patient survival; 5-year survival was 74%, 75.5%, and 77.3% in iHCC, pdHCC, and non-HCC groups, respectively (P = 0.702). Patients with iHCC had no recurrences after transplant, while pdHCC patients experienced 17 recurrences (15.3%) (P = 0.016). Conclusions. iHCC has significantly decreased despite steady increase in number of transplants for hepatocellular carcinoma. Patients with iHCC had excellent outcomes with no tumor recurrence and survival comparable to pdHCC.

背景。我们的目的是评估偶然发现的肝细胞癌(iHCC)随着时间的推移,并比较术前诊断的肝细胞癌(pdHCC)和非肿瘤肝移植的结果。方法。我们对成人移植进行了至少一年的随访研究。根据肝细胞癌的诊断情况将患者分为3组。结果。在1990年至2010年间,移植了887株成虫。其中pdHCC 121例(13.6%),iHCC 32例(3.6%);iHCC的发病率逐年显著下降,与此同时pdHCC的发病率显著增加。1990 - 1995年间,肝移植患者120例,iHCC患者4例(3.3%),pdHCC患者3例(2.5%),而近5年,肝移植患者263例,iHCC患者7例(0.03%),pdHCC患者66例(25.1%)(P < 0.001)。两组患者生存率无显著差异;iHCC、pdHCC和非hcc组的5年生存率分别为74%、75.5%和77.3% (P = 0.702)。移植后iHCC患者无复发,pdHCC患者有17例(15.3%)复发(P = 0.016)。结论。尽管肝细胞癌移植数量稳步增加,但iHCC已显著减少。iHCC患者预后良好,无肿瘤复发,生存期与pdHCC相当。
{"title":"Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation.","authors":"Walid El Moghazy,&nbsp;Samy Kashkoush,&nbsp;Glenda Meeberg,&nbsp;Norman Kneteman","doi":"10.1155/2016/1916387","DOIUrl":"https://doi.org/10.1155/2016/1916387","url":null,"abstract":"<p><p>Background. We aimed to assess incidentally discovered hepatocellular carcinoma (iHCC) over time and to compare outcome to preoperatively diagnosed hepatocellular carcinoma (pdHCC) and nontumor liver transplants. Methods. We studied adults transplanted with a follow-up of at least one year. Patients were divided into 3 groups according to diagnosis of hepatocellular carcinoma. Results. Between 1990 and 2010, 887 adults were transplanted. Among them, 121 patients (13.6%) had pdHCC and 32 patients (3.6%) had iHCC; frequency of iHCC decreased markedly over years, in parallel with significant increase in pdHCC. Between 1990 and 1995, 120 patients had liver transplants, 4 (3.3%) of them had iHCC, and only 3 (2.5%) had pdHCC, while in the last 5 years, 263 patients were transplanted, 7 (0.03%) of them had iHCC, and 66 (25.1%) had pdHCC (P < 0.001). There was no significant difference between groups regarding patient survival; 5-year survival was 74%, 75.5%, and 77.3% in iHCC, pdHCC, and non-HCC groups, respectively (P = 0.702). Patients with iHCC had no recurrences after transplant, while pdHCC patients experienced 17 recurrences (15.3%) (P = 0.016). Conclusions. iHCC has significantly decreased despite steady increase in number of transplants for hepatocellular carcinoma. Patients with iHCC had excellent outcomes with no tumor recurrence and survival comparable to pdHCC. </p>","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/1916387","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34659629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Current Treatment Approaches to HCC with a Special Consideration to Transplantation. 当前肝细胞癌的治疗方法,特别考虑移植。
IF 2.5 Pub Date : 2016-01-01 Epub Date: 2016-06-20 DOI: 10.1155/2016/7926264
N Bhardwaj, M T P R Perera, M A Silva

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The mainstay of treatment of HCC has been both resectional and transplantation surgery. It is well known that, in selected, optimized patients, hepatectomy for HCC may be an option, even in patients with underlying cirrhosis. Resectable patients with early HCC and underlying liver disease are however increasingly being considered for transplantation because of potential for better disease-free survival and resolution of underlying liver disease, although this approach is limited by the availability of donor livers, especially in resectable patients. Outcomes following liver transplantation improved dramatically for patients with HCC following the implementation of the Milan criteria in the late 1990s. Ever since, the rather restrictive nature of the Milan criteria has been challenged with good outcomes. There has also been an increase in the donor pool with marginal donors including organs retrieved following cardiac death being used. Even so, patients still continue to die while waiting for a liver transplant. In order to reduce this attrition, bridging techniques and methods for downstaging disease have evolved. Additionally new techniques for organ preservation have increased the prospect of this potentially curative procedure being available for a greater number of patients.

肝细胞癌(HCC)是全球癌症死亡的第三大原因。肝细胞癌的主要治疗方法是切除和移植手术。众所周知,在选定的、优化的患者中,肝切除术治疗HCC可能是一种选择,即使是有潜在肝硬化的患者。然而,可切除的早期HCC和潜在肝病患者越来越多地被考虑进行移植,因为有可能获得更好的无病生存和潜在肝病的解决,尽管这种方法受到供体肝脏的可用性的限制,特别是在可切除的患者中。在20世纪90年代末实施米兰标准后,肝移植后HCC患者的预后显著改善。从那以后,米兰标准的限制性受到了良好结果的挑战。供体池也有所增加,边缘供体包括使用心脏死亡后取出的器官。即便如此,仍有患者在等待肝移植的过程中死亡。为了减少这种消耗,桥接技术和降低分期疾病的方法已经发展。此外,器官保存的新技术增加了这种潜在治疗程序的前景,可用于更多的患者。
{"title":"Current Treatment Approaches to HCC with a Special Consideration to Transplantation.","authors":"N Bhardwaj,&nbsp;M T P R Perera,&nbsp;M A Silva","doi":"10.1155/2016/7926264","DOIUrl":"https://doi.org/10.1155/2016/7926264","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The mainstay of treatment of HCC has been both resectional and transplantation surgery. It is well known that, in selected, optimized patients, hepatectomy for HCC may be an option, even in patients with underlying cirrhosis. Resectable patients with early HCC and underlying liver disease are however increasingly being considered for transplantation because of potential for better disease-free survival and resolution of underlying liver disease, although this approach is limited by the availability of donor livers, especially in resectable patients. Outcomes following liver transplantation improved dramatically for patients with HCC following the implementation of the Milan criteria in the late 1990s. Ever since, the rather restrictive nature of the Milan criteria has been challenged with good outcomes. There has also been an increase in the donor pool with marginal donors including organs retrieved following cardiac death being used. Even so, patients still continue to die while waiting for a liver transplant. In order to reduce this attrition, bridging techniques and methods for downstaging disease have evolved. Additionally new techniques for organ preservation have increased the prospect of this potentially curative procedure being available for a greater number of patients. </p>","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/7926264","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34731314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
For and against Organ Donation and Transplantation: Intricate Facilitators and Barriers in Organ Donation Perceived by German Nurses and Doctors. 支持和反对器官捐献与移植:德国护士和医生眼中器官捐献中错综复杂的促进因素和障碍。
IF 2.5 Pub Date : 2016-01-01 Epub Date: 2016-08-15 DOI: 10.1155/2016/3454601
Niels Christian Hvidt, Beate Mayr, Piret Paal, Eckhard Frick, Anna Forsberg, Arndt Büssing

Background. Significant facilitators and barriers to organ donation and transplantation remain in the general public and even in health professionals. Negative attitudes of HPs have been identified as the most significant barrier to actual ODT. The purpose of this paper was hence to investigate to what extent HPs (physicians and nurses) experience such facilitators and barriers in ODT and to what extent they are intercorrelated. We thus combined single causes to circumscribed factors of respective barriers and facilitators and analyzed them for differences regarding profession, gender, spiritual/religious self-categorization, and self-estimated knowledge of ODT and their mutual interaction. Methods. By the use of questionnaires we investigated intricate facilitators and barriers to organ donation experienced by HPs (n = 175; 73% nurses, 27% physicians) in around ten wards at the University Hospital of Munich. Results. Our study confirms a general high agreement with the importance of ODT. Nevertheless, we identified both facilitators and barriers in the following fields: (1) knowledge of ODT and willingness to donate own organs, (2) ethical delicacies in ODT, (3) stressors to handle ODT in the hospital, and (4) individual beliefs and self-estimated religion/spirituality. Conclusion. Attention to the intricacy of stressors and barriers in HPs continues to be a high priority focus for the availability of donor organs.

背景。一般公众,甚至卫生专业人员对器官捐献和移植仍然存在重大的促进因素和障碍。医护人员的消极态度被认为是实际进行器官捐献和移植的最大障碍。因此,本文的目的是调查医护人员(医生和护士)在器官捐献和移植过程中遇到的促进因素和障碍的程度,以及它们之间的相互关联程度。因此,我们将各自障碍和促进因素的单一原因与限定因素相结合,并分析了它们在职业、性别、精神/宗教自我归类和自我估计的 ODT 知识方面的差异及其相互影响。研究方法通过问卷调查,我们调查了慕尼黑大学医院十个病房的医护人员(n = 175;73%为护士,27%为医生)在器官捐献方面遇到的错综复杂的促进因素和障碍。研究结果我们的研究证实,人们普遍高度认同器官捐献的重要性。不过,我们在以下几个方面发现了促进因素和障碍:(1) 对无偿献血的了解和捐献自身器官的意愿,(2) 无偿献血中的道德问题,(3) 医院处理无偿献血的压力,(4) 个人信仰和自我估计的宗教/精神。结论。关注 HPs 中错综复杂的压力和障碍仍是提供器官捐献的重中之重。
{"title":"For and against Organ Donation and Transplantation: Intricate Facilitators and Barriers in Organ Donation Perceived by German Nurses and Doctors.","authors":"Niels Christian Hvidt, Beate Mayr, Piret Paal, Eckhard Frick, Anna Forsberg, Arndt Büssing","doi":"10.1155/2016/3454601","DOIUrl":"10.1155/2016/3454601","url":null,"abstract":"<p><p>Background. Significant facilitators and barriers to organ donation and transplantation remain in the general public and even in health professionals. Negative attitudes of HPs have been identified as the most significant barrier to actual ODT. The purpose of this paper was hence to investigate to what extent HPs (physicians and nurses) experience such facilitators and barriers in ODT and to what extent they are intercorrelated. We thus combined single causes to circumscribed factors of respective barriers and facilitators and analyzed them for differences regarding profession, gender, spiritual/religious self-categorization, and self-estimated knowledge of ODT and their mutual interaction. Methods. By the use of questionnaires we investigated intricate facilitators and barriers to organ donation experienced by HPs (n = 175; 73% nurses, 27% physicians) in around ten wards at the University Hospital of Munich. Results. Our study confirms a general high agreement with the importance of ODT. Nevertheless, we identified both facilitators and barriers in the following fields: (1) knowledge of ODT and willingness to donate own organs, (2) ethical delicacies in ODT, (3) stressors to handle ODT in the hospital, and (4) individual beliefs and self-estimated religion/spirituality. Conclusion. Attention to the intricacy of stressors and barriers in HPs continues to be a high priority focus for the availability of donor organs. </p>","PeriodicalId":45795,"journal":{"name":"Journal of Transplantation","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34710456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Transplantation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1